Benzinga's Top #PreMarket Gainers

By: via Benzinga
Dendreon (NASDAQ: DNDN ) soared 9.37% to $3.15 in the pre-market trading after the company posted better-than-expected Q4 results and announced its plans to make PROVENGE available in Europe. Revance Therapeutics (NASDAQ: RVNC ) surged 9.54% to $29.50 in the pre-market session after dropping 10.05% on Friday. Perion Network
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.